<DOC>
	<DOCNO>NCT00229515</DOCNO>
	<brief_summary>The purpose study determine four combination tirofiban+sirolimus elute stent ( SES ) , tirofiban+bare metal stent ( BMS ) , abciximab+SES , abciximab+BMS possible gold standard treatment ST-segment elevation myocardial infarction term efficacy cost-efficacy .</brief_summary>
	<brief_title>Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Versus Abciximab SES Versus BMS AMI</brief_title>
	<detailed_description>The combination abciximab plus bare metal stent ( BMS ) currently consider standard therapy AMI . The use sirolimus elute stent ( SES ) relate reduction need urgent target vessel revascularization ( TVR ) . With current acquisition price abciximab SES , replace abciximab tirofiban , administer single high-dose bolus ( SHDB ) regimen , promise strategy would preserve financial resource . In recent study combination tirofiban SES result associate overall low major adverse cardiovascular event ( MACE ) rate respect abciximab plus BMS . However , since conclusion drawn yet regard relative contribution specific GP IIb/IIIa inhibitor stent type respect , combination abciximab SES may associate even low event rate respect SHDB tirofiban SES , thus offset high initial cost . Comparison ( ) : four strategy ( SHDB tirofiban + BMS , SHDB tirofiban + SES , abciximab + BMS , abciximab + SES ) compare determine possible gold standard treatment ST-segment elevation myocardial infarction term efficacy cost-efficacy .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Abciximab</mesh_term>
	<mesh_term>Tirofiban</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<mesh_term>Immunoglobulin Fab Fragments</mesh_term>
	<mesh_term>Krestin</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>ST segment elevation myocardial infarction Schedule primary percutaneous coronary intervention Informed consent Administration fibrinolytic GP IIb/IIIa inhibitor treatment current acute myocardial infarction within 1 month History bleed diathesis allergy study drug Major surgery within 30 day Limited life expectancy , e.g . neoplasm , others Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Myocardial infarction</keyword>
	<keyword>Revascularization</keyword>
	<keyword>Stent</keyword>
	<keyword>ST segment elevation</keyword>
</DOC>